1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. The New England Journal of Medicine. 1999;341:1725-1730. DOI: 10.1056/NEJM199912023412303
2. van Gelder T, Hesselink DA. Mycophenolate revisited. Transplant International. 2015;28:508-515. DOI: 10.1111/tri.12554
3. Larson TS, Dean PG, Stegall MD, et al. Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus. American Journal of Transplantation. 2006;6:514-522. DOI: 10.1111/j.1600-6143.2005.01177.x
4. Flechner SM, Goldfarb D, Modlin C, et al. Kidney transplantation without calcineurin inhibitor drugs: A prospective, randomized trial of sirolimus versus cyclosporine. Transplantation. 2002;74:1070-1076. DOI: 10.1097/01.TP.0000037984.17605.B9
5. Ganschow R, Pollok JM, Jankofsky M, et al. The role of everolimus in liver transplantation. Clinical and Experimental Gastroenterology. 2014;7:329-343. DOI: 10.2147/CEG.S41780